BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 22410071)

  • 21. Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation.
    Castells L; Vargas V; Rodríguez F; Allende H; Buti M; Sánchez-Avila JF; Jardí R; Margarit C; Pumarola T; Esteban R; Guardia J
    Liver Transpl; 2002 Oct; 8(10):892-900. PubMed ID: 12360430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome and risk factors of de novo autoimmune hepatitis in living-donor liver transplantation.
    Miyagawa-Hayashino A; Haga H; Egawa H; Hayashino Y; Sakurai T; Minamiguchi S; Tanaka K; Manabe T
    Transplantation; 2004 Jul; 78(1):128-35. PubMed ID: 15257051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 'De novo' and 'recurrent' autoimmune hepatitis after liver transplantation: A comprehensive review.
    Kerkar N; Yanni G
    J Autoimmun; 2016 Jan; 66():17-24. PubMed ID: 26377632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined HLA-DR and -DQ disparity is associated with a stable course of ulcerative colitis after liver transplantation for primary sclerosing cholangitis.
    Cholongitas E; Papatheodoridis GV; Zappoli P; Giannakopoulos A; Patch D; Marelli L; Shusang V; Kalambokis G; Shirling G; Rolando N; Burroughs AK
    Liver Transpl; 2007 Apr; 13(4):552-7. PubMed ID: 17394153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence, detection rate and outcome of cytomegalovirus infection in ulcerative colitis patients requiring colonic resection.
    Maconi G; Colombo E; Zerbi P; Sampietro GM; Fociani P; Bosani M; Cassinotti A; Casini V; Russo A; Ardizzone S; Porta M; Bianchi Porro G
    Dig Liver Dis; 2005 Jun; 37(6):418-23. PubMed ID: 15893280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glutathione S-transferase T1 mismatch constitutes a risk factor for de novo immune hepatitis after liver transplantation.
    Aguilera I; Sousa JM; Gavilán F; Bernardos A; Wichmann I; Nuñez-Roldán A
    Liver Transpl; 2004 Sep; 10(9):1166-72. PubMed ID: 15350010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies against cytokeratin 8/18 in a patient with de novo autoimmune hepatitis after living-donor liver transplantation.
    Inui A; Sogo T; Komatsu H; Miyakawa H; Fujisawa T
    Liver Transpl; 2005 May; 11(5):504-7. PubMed ID: 15838910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. De novo autoimmune hepatitis following liver transplantation for primary biliary cirrhosis.
    Rodríguez-Diaz Y; Reyes-Rodriguez R; Dorta-Francisco MC; Aguilera I; Perera-Molinero A; Moneva-Arce E; Aviles-Ruiz JF
    Transplant Proc; 2006 Jun; 38(5):1467-70. PubMed ID: 16797335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytomegalovirus infection after liver transplantation: prophylaxis and preemptive treatment--a single-center experience.
    Perrella A; Esposito C; Ioia G; Campanella L; Taglialatela D; Cuomo O
    Transplant Proc; 2010 May; 42(4):1226-8. PubMed ID: 20534267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Childhood autoimmune liver disease: indications and outcome of liver transplantation.
    Chai PF; Lee WS; Brown RM; McPartland JL; Foster K; McKiernan PJ; Kelly DA
    J Pediatr Gastroenterol Nutr; 2010 Mar; 50(3):295-302. PubMed ID: 20118802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients.
    Molmenti EP; Netto GJ; Murray NG; Smith DM; Molmenti H; Crippin JS; Hoover TC; Jung G; Marubashi S; Sanchez EQ; Gogel B; Levy MF; Goldstein RM; Fasola CG; Gonwa TA; Klintmalm GB
    Liver Transpl; 2002 Jun; 8(6):519-26. PubMed ID: 12037782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors of cytomegalovirus infection after living donor liver transplantation.
    Akamatsu N; Sugawara Y; Kaneko J; Kishi Y; Makuuchi M
    Hepatogastroenterology; 2005; 52(61):197-9. PubMed ID: 15783029
    [TBL] [Abstract][Full Text] [Related]  

  • 33. De novo autoimmune hepatitis following liver transplantation: a case report.
    Di Cocco P; Barletta A; Clemente K; D'Angelo M; Greco S; Mazzotta C; Orlando G; Rizza V; Famulari A; Grimaldi A; Pisani F
    Transplant Proc; 2008; 40(6):2073-4. PubMed ID: 18675134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis.
    Ichai P; Duclos-Vallée JC; Guettier C; Hamida SB; Antonini T; Delvart V; Saliba F; Azoulay D; Castaing D; Samuel D
    Liver Transpl; 2007 Jul; 13(7):996-1003. PubMed ID: 17370335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of donor-recipient cytomegalovirus serology on adult liver transplantation: a single center experience.
    Tryphonopoulos P; Weppler D; Morris MI; Russo C; Nishida S; Levi DM; Moon J; Tekin A; Selvaggi G; Island E; Arosemena L; Ruiz P; Tzakis AG
    Transplantation; 2011 Nov; 92(9):1051-7. PubMed ID: 21876474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful treatment of de novo autoimmune hepatitis and cirrhosis after pediatric liver transplantation.
    Gibelli NE; Tannuri U; Mello ES; Cançado ER; Santos MM; Ayoub AA; Maksoud-Filho JG; Velhote MC; Silva MM; Pinho-Apezzato ML; Maksoud JG
    Pediatr Transplant; 2006 May; 10(3):371-6. PubMed ID: 16677364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytomegalovirus colitis complicating ulcerative colitis in the steroid-naive patient.
    Pfau P; Kochman ML; Furth EE; Lichtenstein GR
    Am J Gastroenterol; 2001 Mar; 96(3):895-9. PubMed ID: 11280572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Severe systemic cytomegalovirus infections in patients with steroid-refractory ulcerative colitis treated by an oral microemulsion form of cyclosporine: report of two cases.
    Piton G; Dupont-Gossart AC; Weber A; Herbein G; Viennet G; Mantion G; Carbonnel F
    Gastroenterol Clin Biol; 2008 May; 32(5 Pt 1):460-4. PubMed ID: 18359591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
    Maggiore G; Riva S; Sciveres M
    Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.